Literature DB >> 8406025

Cloning and sequence analysis of cDNAs encoding human hippocampus N-methyl-D-aspartate receptor subunits: evidence for alternative RNA splicing.

R L Foldes1, V Rampersad, R K Kamboj.   

Abstract

Several cDNA clones encoding human N-methyl-D-aspartate receptor (hNR1) subunit polypeptides were isolated from a human hippocampus library. Degenerate oligodeoxyribonucleotide (oligo) primers based on the published rat NR1 (rNR1) amino acid (aa) sequence [K. Moriyoshi et al. Nature 354 (1991) 31-37] amplified a 0.7-kb fragment from a human hippocampus cDNA library, via the polymerase chain reaction (PCR). This fragment was used as a probe for subsequent hybridization screening. DNA sequence analysis of 28 plaque-purified clones indicated three distinct classes, designated hNR1-1, hNR1-2 and hNR1-3, presumably generated by alternative RNA splicing. One of these clones, hNR1-1(5A), was isolated as a full-length cDNA. The hNR1-2 and hNR1-3 cDNAs represented 66.8 and 98.9%, respectively, of the total aa coding information predicted for the polypeptides. The hNR1 cDNAs demonstrated an 84-90.8% nucleotide (nt) identity with the corresponding rodent cDNAs. The nt sequences of hNR1-1, hNR1-2 and hNR1-3 would encode 885-, 901- and 938-aa proteins, respectively, that have 99.1-99.8% identity with the corresponding rodent NR1 (roNR1) subunits. The changes between the predicted aa sequences of hNR1 and the corresponding roNR1 subunits are confined to the extracellular N-terminal regions. We have also identified two possible allelic variations of the hNR1-3 cDNA that result in aa substitutions in the extracellular N- and C-terminal regions. One of these naturally occurring aa variations is situated within a potential glutamate-binding site.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8406025     DOI: 10.1016/0378-1119(93)90309-q

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  5 in total

1.  Alternative RNA splicing of the NMDA receptor NR1 mRNA in the neurons of the teleost electrosensory system.

Authors:  D Bottai; L Maler; R J Dunn
Journal:  J Neurosci       Date:  1998-07-15       Impact factor: 6.167

2.  The Expression of NMDA Receptor 1 Correlates with Clinicopathological Parameters in Cutaneous Squamous Cell Carcinoma.

Authors:  Minju Kang; Jae Hoon Cho; Ja Kyung Koo; Sun Up Noh; Mi-Yeon Kim; Hoon Kang; Shin Taek Oh; Hyung-Ok Kim; Young Min Park
Journal:  Ann Dermatol       Date:  2009-11-30       Impact factor: 1.444

3.  Expression of the hippocampal NMDA receptor GluN1 subunit and its splicing isoforms in schizophrenia: postmortem study.

Authors:  Monika Vrajová; Frantisek Stastný; Jirí Horácek; Jan Lochman; Omar Serý; Sona Peková; Jan Klaschka; Cyril Höschl
Journal:  Neurochem Res       Date:  2010-03-05       Impact factor: 3.996

4.  Molecular pharmacology of human NMDA receptors.

Authors:  Maiken Hedegaard; Kasper B Hansen; Karen T Andersen; Hans Bräuner-Osborne; Stephen F Traynelis
Journal:  Neurochem Int       Date:  2011-12-17       Impact factor: 3.921

5.  Cloning and Phylogenetic Analysis of NMDA Receptor Subunits NR1, NR2A and NR2B in Xenopus laevis Tadpoles.

Authors:  Rebecca C Ewald; Hollis T Cline
Journal:  Front Mol Neurosci       Date:  2009-09-11       Impact factor: 5.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.